title: [Reevaluation of antithyroid drug therapy in Graves disease].
abstract: Though antithyroid medical therapy has been used for several decades in the medical treatment of hyperthyroidism, only recently has attention been drawn towards prospective controlled trials concerning the effect in relation to dosage as well as the dosage related to side effects. A review is given in relation to recent investigations on treatment strategies in various parts of the world as well as the most frequently used strategies in Europe. Special attention is given to treatment principles in relation to pregnancy, children and adolescents as well as patients with eye symptoms. Antithyroid drug therapy of hyperthyroidism is a frequent and successful treatment strategy in Europe. Globally, there are still large discrepancies in the treatment strategies, related rather to conventions than to a rational attitude.
authors.affiliation: Medicinsk afdeling P, Rigshospitalet, København.
authors.forename: U F
authors.initials: UF
authors.lastname: Feldt-Rasmussen
authors.forename: D
authors.initials: D
authors.lastname: Glinoer
authors.forename: J
authors.initials: J
authors.lastname: Orgiazzi
mesh_terms: D013956:Antithyroid Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005060:Europe; D005069:Evaluation Studies as Topic; D006111:Graves Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D014481:United States
chemical_list: D013956:Antithyroid Agents